SCHEMBL783180

SCHEMBL783180

[Zn]c1ccccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL2988330 0.97
Hydrochloric Acid SCHEMBL1018198 0.97
Bromide SCHEMBL220277 0.97
Formic Acid SCHEMBL28007907 0.85 NPC1 (0.47)
Tetrahydrofuran SCHEMBL6005013 0.80 KMT2A (0.36)
SCHEMBL221242 0.73 KMT2A (0.76)
SCHEMBL10405315 0.73 MEN1 (0.61)
SCHEMBL29391624 0.73 KMT2A (0.76)
SCHEMBL6574416 0.71 KMT2A (0.73)
SCHEMBL11133606 0.71 KMT2A (0.73)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111195531-B Hybrid material of multi-pyridine zinc complex modified MIL-101, preparation method and application of hybrid material in catalyzing degradation of organic phosphorus 安徽师范大学 2022-08-02 CN claimed
CN-111195531-A Hybrid material of multi-pyridine zinc complex modified MIL-101, preparation method and application of hybrid material in catalyzing degradation of organic phosphorus 安徽师范大学 2020-05-26 CN claimed
CN-111032836-A Lubricating oil compositions containing sulfur-phosphorus free zinc compounds and methods for preventing or reducing low speed pre-ignition in direct injection spark ignition engines 雪佛龙奥伦耐有限责任公司 2020-04-17 CN claimed
US-12582179-B2 Antimicrobial dyes for facemasks BMG (BRITISH MEDICAL GROUP) LIMITED (GB) 2026-03-24 US disclosed
EP-4509122-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF Bayer Aktiengesellschaft (DE) 2025-02-19 EP disclosed
EP-4188930-B1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF BAYER AG (DE) 2024-10-23 EP disclosed
EP-4405347-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS Xenon Pharmaceuticals Inc. (CA) 2024-07-31 EP disclosed
EP-4405344-A2 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS Xenon Pharmaceuticals Inc. (CA) 2024-07-31 EP disclosed
CN-117279905-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-22 CN disclosed
US-20230382913-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF ORGANOVO, INC. 2023-11-30 US disclosed
US-11773094-B2 Farnesoid X receptor agonists and uses thereof ORGANOVO, INC. (US) 2023-10-03 US disclosed
EP-0724566-B1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 1998-10-07 EP disclosed
US-5663180-A ANTIARTHRITIC, ANTIINFLAMMATORY AGENTS G.D. SEARLE & CO. (US) 1997-09-02 US disclosed
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5420287-A 1,2 diarylcyclopentenyl compounds for the treatment of inflammation G. D. SEARLE & CO. (US) 1995-05-30 US disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed
US-5344991-A Sulfonyl or sulfamyl derivatives for treatment of arthritis and pain G.D. SEARLE & CO. (US) 1994-09-06 US disclosed